$CSW

Armes Joseph B sold $518K of CSW

Armes Joseph B (Chairman, President & CEO) sold 1,500 shares of CSW INDUSTRIALS, INC. (CSW) at $345.16 ($0.52M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Armes Joseph B
Published Aug 17, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CSW
Neutral
medium confidence
Mentioned
$CSW
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSWNeutralLow
01

Why it matters

Because it is an insider sale (not a buy) and is pre-arranged, it is more relevant for sentiment monitoring than for fundamental repricing. Without accompanying company news, the trading impact should be modest.

02

Market read

A routine 10b5-1 insider sale is disclosed; traders may briefly reassess sentiment but there is no new CSW business or financial information.

03

What to watch

The article provides only the sale details; it does not include context such as total planned sales, tax-motivated selling, or whether other insiders sold/bought around the same time.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-17, transaction dated 2026-08-14

Background

The article is a SEC Form 4 insider transaction disclosure for CSW, reporting an open-market sale by the CEO/chairman under a 10b5-1 plan.

Company-level read

Ticker impact

$CSWNeutralMedium confidence
Context

CSW CEO and chairman Armes Joseph B sold 1,500 shares at $345.1574 on 2026-08-14 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived impact; any move would be sentiment-driven rather than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. No new operational, financial, or regulatory facts about CSW are disclosed in the text.

Market effects

No sector-level implications are provided; the disclosure is company-specific and limited to an insider sale.

None indicated.

None indicated.

Counterpoint

Traders may overreact to insider selling, but the presence of a pre-arranged 10b5-1 plan suggests the sale may be routine and not a forward-looking negative signal.

Key entities

  • CSW

    CSW Industrials, Inc., the company whose insider transaction is disclosed.

  • Armes Joseph B

    Chairman, President and CEO who sold 1,500 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSWMedAI 8/10

CSW (NYSE:CSW) Beats Q2 CY2026 Sales Expectations

CSW (NYSE: CSW) reported Q2 CY2026 revenue of $350.7 million, up 33% year on year, exceeding market expectations by 2.4%. Non-GAAP adjusted EPS was $3.84, 10.9% above analysts’ consensus. Net income rose to $50 million, and net debt was $815 million with net leverage of 2.37x, within its 1-3x target range.

$CSWHighAI 9/10

CSW (CSW) Q1 Earnings Report Preview: What To Look For

CSW (NYSE: CSW) is set to report Q1 earnings Tuesday before market open. The company missed revenue and adjusted operating income estimates last quarter, with revenue of $233 million (+20.3% YoY). For Q1, analysts expect revenue up 31.8% YoY. CSW’s average analyst price target is $322.71 versus a $281.22 share price.